External Ventricular Drain Infections by Anderson C.O. Tsang & Gilberto K.K. Leung
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
7 
External Ventricular Drain Infections 
Anderson C.O. Tsang and Gilberto K.K. Leung 
The University of Hong Kong 
Hong Kong 
 
1. Introduction  
The insertion of ventricular catheter is one of the most commonly performed procedures in 
neurosurgery. External ventricular drainage (EVD) is a reliable, accurate and cost-effective 
means of monitoring intracranial pressure (ICP) in acute traumatic brain injuries, 
subarachnoid hemorrhages, hemorrhagic and ischemic strokes. Another indication for EVD 
is the need for temporary cerebrospinal fluid (CSF) diversion for the treatment of acute 
hydrocephalus caused by intraventricular hemorrhages (IVH), infective meningitis, and 
space occupying lesions that obstruct CSF flow such as intracerebral hematomas and 
tumors. Under these circumstances, EVD serves to monitor disease progression and 
response to treatment until the offending pathology resolves or is dealt with definitively. As 
a means of CSF diversion, EVD has the advantage over permanent shunting in that CSF 
drainage is controlled and monitored. It can also be used as an access to the ventricles for 
intraventricular fibrinolysis treatment in IVH, antibiotics instillation in ventriculitis, and the 
performance of ventriculography (Gaberel, et al., 2011). However, EVD is only a 
temporizing measure for the treatment of hydrocephalus. If permanent CSF diversion is 
required, conversion into an internalized system using, for example, ventriculo-peritoneal 
shunting is necessary.  
2. Surgical procedure 
Depending on the available expertise and facilities, EVD may be performed by 
neurosurgeons, general surgeons, emergency physicians or intensivists in the operating 
theatre or in the ward (Ehtisham, et al., 2009). Under aseptic conditions, a scalp incision is 
made over the insertion site. Commonly, the Kocher’s point is used which is located 2.5 cm 
lateral to the midline (or at the mid-pupillary line), 11 cm posterior to the nasion. To avoid 
the motor cortex, it should be at least one cm anterior to the coronal suture. A burr hole is 
then performed. After opening the dura, a ventricular catheter is passed into the ipsilateral 
lateral ventricle transcerebrally. This may be done free-handedly or under the guidance of 
ultrasound or stereotaxy. After confirming CSF drainage, the distal end of the catheter is 
tunneled subcutaneously and allowed to exit the skin approximately 5-cm away from the 
burr hole site. The catheter is connected to a closed external drainage system with an 
attached ICP monitoring transducer. Other authorities may elect to close the ventricular 
catheter with a subcutaneous reservoir without skin tunneling or externalization of the 
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catheter. CSF drainage is achieved post-operatively by percutaneous needle puncture of the 
reservoir. In general, prophylactic antibiotics would be given perioperatively. Post-operative 
antibiotics may be given depending on individual surgeons’ preferences or protocols. The 
implications of these variations in practices will be discussed later.  
3. External ventricular drain infection 
Complications arising from EVD include hemorrhage, misplacement, dislodgement, 
disconnection, blockage, and, most significantly, infection. EVD-related infections may 
lead to further serious complications such as ventriculitis, meningitis, cerebritis, brain 
abscess and subdural empyema. These complications can cause profound neurological 
damages, significant morbidities and mortalities. Even when successfully treated, EVD-
related infections may impair rehabilitation progress and negatively affect the overall 
prognosis of the initial conditions. An infected EVD contraindicates immediate permanent 
shunting and may therefore delay definitive CSF diversion. It significantly prolongs 
hospital stay and increases cost. Lyke et al calculated the cost of treatment and hospital 
stay days of a patient with ventriculitis to be as high as US$85,674.27 and 30.8 days (95% 
CI, 23.9–37.7, P=.009), respectively, compared with $55,339.21 and 22.6 days (95% CI, 19.1–
26.0, P=.03) in those without ventriculitis. Patients in the infected group also suffered 
from more severe neurological damages (RR 5.33, 95% CI, 1.18–32.5) (Lyke, et al., 2001). 
EVD-related infections require immediate and prolonged treatment once detected. 
Empirical antibiotics with good CSF penetration should be given to cover the common 
offending organisms. The commonly used agents are cephalosporins and rifampicin. 
Intraventricular vancomycin may be used for resistant organisms. Revision of the EVD at 
a different site should be considered if CSF diversion or ICP monitoring is still required 
(Beer, et al., 2009). 
3.1 Mechanisms of infection 
The presence of an EVD essentially externalizes the intra-cranial cavity and ventricular 
system, and is a potential route for retrograde infection. The ventricular catheter as an 
indwelling foreign body is prone to bacterial colonization that may result from other 
unrelated sources such as systemic bacteremia. The current opinion is that EVD-related 
infections may arise from either (i) inoculation of skin flora during insertion, and/or (ii) 
contamination and colonization of the drainage system during the post-operative period, 
with subsequent retrograde infections (Lo, et al., 2007). The risk of inoculation is related to 
the sterility of the insertion procedure. It may increase with repeated revisions due to 
elective replacement or other clinical indications. The risk of colonization and contamination 
is affected by the manipulation of the drainage system, EVD maintenance protocol, and the 
technique of insertion (Hetem, et al., 2010). The mechanism is likely to be multifactorial and 
varies between individual patients. 
3.2 Definition of infection 
There is to date no universally accepted definition for EVD-related infection. Most 
authorities defined EVD-related meningitis or ventriculitis as the presence of a positive 
CSF microbiological culture (Lo, et al., 2007; Mayhall, et al., 1984; Schade, et al., 2005). CSF 
culture growing commensal organisms without other signs of infection such as altered 
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CSF chemistry, meningism, systemic sepsis, or the perceived need for antibiotic therapy, 
are considered by many to represent colonization of the EVD only rather than a genuine 
infection (Lozier, et al., 2008). This definition has been modified from the respective 
criteria set by the Centers for Disease Control and Prevention (Horan, 2004). Meanwhile 
some authorities adopt a more stringent definition of infection that requires the presence 
CSF pleiocytosis and biochemical changes (elevated CSF protein and/or decreased 
glucose), together with the presence of a positive CSF culture (Pfisterer, et al., 2003). 
Because of the varied definitions, the reported incidences of EVD-related infections 
ranged widely from 0 to 27% with a mean of 8.8% (Lozier, et al., 2008). This makes risk 
factors analysis, and the comparisons between different preventive and management 
protocols difficult. 
3.3 Bacteriology 
Coagulase-negative Staphylococcus is consistently reported to be the most common bacteria 
isolated in patients with EVD-related infections, accounting for up to 47% of infected cases 
(Zabramski, et al., 2003). Other common organisms include Enterococcus, Enterobacter and 
Staphylococcus aureus. This pattern coincides with that of the usual skin flora and hospital 
environment although the bacteriology may also be influenced by the presence of different 
nosocomial microorganisms in different institutions. Gram-positive organisms are 
classically associated with ventriculitis, and some centers, including the author’s institution, 
noted that ventriculitis associated with EVD were not uncommonly caused by gram-
negative bacteria such as Klebsiella. This is postulated to be a nosocomial colonization caused 
by prolonged hospital stay and the selection pressure from prophylactic antibiotics targeting 
gram-positive organisms (Lyke, et al., 2001).  
3.4 Risk factors  
Many studies have been conducted to indentify risk factors for EVD-related infections. 
Critical reviews of these published series have identified several important factors which 
will be discussed in the following sections (Dasic, et al., 2006; Hoefnagel, et al., 2008; Lozier, 
et al., 2008). 
3.4.1 Subarachnoid hemorrhage (SAH) and Intraventricular hemorrhage (IVH) 
The majority of published series reported statistically significant higher incidence of EVD-
related infections in patients with SAH or IVH when compared with patients with non-
hemorrhagic pathologies (Hoefnagel, et al., 2008; Stenager, et al., 1986). This has been 
postulated to be the result of frequent manipulations of the drainage system for flushing 
blocked EVD, the infusion of fibrinolytic agents, and the higher chance of EVD revision in 
these subgroups of patient with hemorrhages (Hoefnagel, et al., 2008). In a review by Lozier 
et al, the risk of infection was found to be 6 to 10% higher in patients with hemorrhages 
(Lozier, et al., 2008). 
3.4.2 Craniotomy and other neurosurgical procedures 
The conduction of craniotomies or other neurosurgical procedures were found to be a risk 
factor for EVD-related infections when compared with patients who had received EVD 
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alone. Holloway et al studied 584 patients of whom 211 had undergone neurosurgical 
procedures other than the insertion of EVD. The infection rate in this group of patients was 
15.2%, compared with 7.8% in the EVD-only group (Holloway, et al., 1996). Mayhall et al 
also reported that 68% of patients with EVD-related infections had other neurosurgical 
procedures performed, while only 40% non-infected patients did (P =0.02) (Mayhall, et al., 
1984). 
3.4.3 Venue of insertion and skill level of surgeon 
Many authorities advocated the operating theatre as a preferred venue for EVD insertion 
(Bader, et al., 1995). However, Roitberg et al, and Lo et al, demonstrated separately that 
inserting EVDs in the intensive care units, emergency rooms or neurosurgical wards was 
not inferior in terms of infection risks or other complications (Lo, et al., 2007; Roitberg, et al., 
2001). The location of insertion did not appear to affect the risk of infection provided that 
strict aseptic technique was used. There was also no significant difference amongst EVDs 
that were performed by neurosurgical trainees, consultants or neurointensivists (Ehtisham, 
et al., 2009; Lo, et al., 2007). 
3.4.4 Duration of drainage 
The literature was very much divided on the issue of whether and how the duration of 
external CSF drainage may affect the risk of infection. A recent multivariate analysis of 
seven series with a total of 2199 EVDs in 2113 patients demonstrated no association between 
the risk of infection and the duration of drainage (Lozier, et al., 2002). The timing of EVD-
related infections appeared to follow a normal distribution during the first five post-
operative days, and the majority of infections occurred between day two and day 11. Lo et al 
postulated that these early infections may arise from initial inoculations, which developed 
into detectable infections after variable incubation periods of around five days (Hetem, et 
al., 2010). A delayed peak of infection has also been observed after day 20, but the small 
number of reported cases rendered confirmation difficult (Winfield, et al., 1993).  
Based on the belief that the risk of infection would increase with prolonged EVD, some 
authorities have  advocated elective revisions of EVD after a fixed interval of, say, five days. 
However, the review by Park et al on 595 patients with EVD insertions found that the daily 
infection rates would plateau after day 4 post-insertion, and remain steady beyond day 10 
(Park, et al., 2004). In reported series that adopted the practice of regular elective EVD 
revisions, revisions were not found to decrease infection rate significantly, and may actually 
increase it (Lo, et al., 2007; Wong, et al., 2002). Current evidence indicates that although the 
duration of drainage is an independent risk factor for EVD-related infections, routine 
revision of EVD in the absence of other clinical indications is not recommended. It is, 
however, prudent and logical to minimize the duration of drainage and to remove the 
catheter as soon as it is safe and feasible to do so. 
3.4.5 Manipulation of the EVD system 
Manipulations and opening of the otherwise closed EVD system for CSF sampling or 
flushing may introduce microorganisms and potentially cause infection. Aucoin et al 
reported a 6% increase in relative risk of infection for patients whose EVD was flushed 
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with bacitracin solution (Aucoin, et al., 1986). A previously published report by the 
present authors also demonstrated intraventricular urokinase infusion as one of the risk 
factors for infection (Leung, et al., 2007). Historically, CSF was sampled routinely and 
indeed daily in some centers in an attempt to pick up early infections. This practice has 
been shown to increase the risk of infection; decreasing the frequency of CSF sampling to 
once every 3 days was associated with a lower incidence of ventriculitis (OR 0.44, 95% CI 
0.22-0.88, p = 0.02) (Williams, et al., 2011). CSF sampling should be performed when there 
is clinical suspicion of infection but routine sampling is no longer encouraged (Korinek, et 
al., 2005).  
In our center, we adopt a minimal-touch technique in handling EVD systems. If CSF 
sampling or infusion of intraventricular medication is required, we employ strict hand 
hygiene protocol, sterile gloving, and disinfection of the 3-way connector site with 
povidone-iodine before breaching the drainage system. Although it is difficult to 
demonstrate conclusively the benefit of these practices, many authorities in the literature 
support this logical awareness of strict hygiene in their EVD maintenance protocol (Korinek, 
et al., 2005; Leverstein-van Hall, et al., 2010). CSF leakage around the site of EVD has been 
identified as another major risk factor (Korinek, et al., 2005; Leverstein-van Hall, et al., 2010; 
Lyke, et al., 2001). Lyke et al reported that CSF leakage conferred a significant risk for 
ventriculitis (OR, 7.33; 95% CI, 1.05–37.47; P=.003) (Lyke, et al., 2001). Meticulous suturing of 
skin after EVD removal and better coupling of catheter size and dural puncture hole may 
effectively reduce the risk of infection (Korinek, et al., 2005). Interestingly, accidental 
disconnection, dislodgement or changes in the components of the system were not found to 
increase infection risks. 
3.4.6 Prophylactic antibiotics 
Antibiotic prophylaxis is a widely used strategy to prevent EVD-related infections. There is, 
however, no consensus as to what and for how long it should be given. As demonstrated by 
a recent survey by McCarthy et al, responders in Europe favored a single dose of antibiotics 
given immediately before the operation, while those from Asia and North America tend to 
cover also the whole period of post-operative drainage (McCarthy, et al., 2010). In a meta-
analysis by Sonabend et al, the use of prophylactic antibiotics was found to significantly 
reduce the risk of EVD- related infections, but the authors also noted that the available data 
were of suboptimal quality, and that there were wide variations in the types of antibiotics 
used and the definitions of infection (Sonabend, et al., 2011).  
Several randomized controlled trials (RCT) have been conducted to investigate the 
prolonged use of prophylactic antibiotics. In one study, co-trimoxazole given for the whole 
lifespan of an EVD did not result in a lower infection rate (Blomstedt, 1985). Another study 
found that the prolonged use of ampicillin/sulbactam and aztreonam resulted in a lower 
infection rate compared with a single dose of perioperative ampicillin/sulbactam. However 
the former was associated with infections caused by  resistant organisms such as methicillin-
resistant Staphylococcus aureus, and gram-negative organisms such as Pseudomonas or 
Klebsiella (Poon, et al., 1998). The role of prolonged systemic antibiotics and the best 
regimens are yet to be defined.  
Apart from systemic antibiotics, some investigators have described the possible beneficial 
effect of prophylactic intraventricular antibiotics. Ragel et al demonstrated that using 
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prophylactic intraventricular vancomycin and gentamicin together with systemic antibiotics 
significantly decreased the risk of infection in shunted patients (Ragel, et al., 2006). Whether 
this beneficial effect can be translated to EVD remains to be confirmed. 
3.4.7 Coated ventricular catheter 
The potential roles of coated EVD catheter have received a lot of attention and research 
effort in recent years. The underlying rationale is that coating the surface of the catheter 
with special materials or antibiotics may decrease bacterial colonization and thus prevent 
infection. The findings were controversial depending on the coating material used. One RCT 
did not show any benefit with the use of hydrogel-coated catheters presoaked in bacitracin 
solution (Kaufmann, et al., 2004). Silver-coated catheters were first used in central venous 
line with equivocal results (Bach, et al., 1999; Kalfon, et al., 2007). Thereafter, two 
retrospective analyses have been conducted using silver nanoparticle-impregnated catheters 
for EVD. Both studies showed significant reduction in infection rates and a trend of reduced 
bacterial colonization despite the studies’ small sample sizes (Fichtner, et al., 2010; Lackner, 
et al., 2008). 
Antibiotics-impregnated catheter is an important development. To date, two RCTs and 3 
observational studies have been conducted to investigate the efficacy of antibiotics-
impregnated catheters. Zabramski et al studied minocycline/rifampicin-coated catheters 
(M/R catheters) in a RCT involving 149 cases of M/R catheters and 139 controls with 
standard silastic catheters. Both groups received systemic antibiotics throughout the lifespan 
of the EVD. The infection rate in the M/R catheter group was 1.3% compared with 9.6% in 
the standard EVD group (P<0.0012) (Zabramski, et al., 2003). Sonabend et al pooled the data 
of the above RCT with other studies for a meta-analysis, and demonstrated a risk ratio of 
0.19 (95%CI 0.07-0.52) for EVD-related infections in patients with antibiotics-impregnated 
catheters (Sonabend, et al., 2011). A more recent RCT by Abla et al compared the efficacy of 
M/R catheters and clindamycin/rifampicin-impregnated catheters (C/R catheters). A total 
of 129 patients were randomized into receiving either M/R or C/R catheters in a 3-monthly 
rotation. The mean duration of EVD was 12.7 and 11.8 days in the M/R and C/R groups, 
respectively. A single dose of perioperative cefuroxime was given to 45% of M/R group and 
55% of C/R group patients. The study demonstrated a remarkable 0% infection rate in both 
groups of patients (Abla, et al., 2011). Only one patient showed a minimal growth of 
Staphylococcus epidermidis in one culture broth, with the culture in another broth, blood agar, 
gram stain being negative for the same CSF specimen. The potential side-effects of these 
catheters include allergy to the impregnated antibiotics and the selection of resistant 
organisms. To date, there have been no reports of antibiotics-impregnated catheters 
increasing the risk of selection of resistant organisms. A drawback of these catheters is the 
relaively high cost which may prevent its adoption world-wide.  
3.4.8 Subcutaneous catheter tunnel  
Historically, one major development was the tunneling technique which created a 
subcutaneous tract between the burr hole and catheter exit site. Freidman et al first 
proposed subcutaneous tunneling of the EVD catheter, and reported an infection rate of 0% 
in a series of 100 patients (Friedman & Vries, 1980). Similar principle of preventing 
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ascending infection has been applied to the design of indwelling intravenous catheters and, 
indeed, intravenous Broviac catheter has been described for cerebrospinal fluid (CSF) 
drainage. Although infection continued to be reported with the tunneling technique, the 
latter has become standard neurosurgical practice. Since then this practice has been widely 
adopted in the majority of neurosurgical centers. The idea was further elaborated by 
Khanna et al who advocated the construction of a long subcutaneous tunnel which exits 
over the anterior chest or abdominal wall. His group demonstrated an inverse relationship 
between tunnel length and infection rate (Khanna, et al., 1995). The rationale of this 
extended-tunnel technique was that bacterial contamination of the ventricular catheter at the 
site of skin penetration would act an important source of ascending infection, and that 
removing this site from the central nervous system would reduce the risk of infection. The 
disadvantages of this long-tunnel EVD include the presence of a large dead space that is 
theoretically prone to blockage, and the requirement of general anesthesia for the removal of 
the system. In our center we have previously used long-tunnel EVD which will be disucssed 
in the next section.  
4. Extended-tunnel EVD 
The procedure is performed with prophylactic antibiotics cover using intravenous 
cefazoline (2 grams) or co-trimoxazole (960 mg). A standard burr hole is made at the 
Kocher’s point or posterior parietal region. An extended subcutaneous tunnel measuring 40 
to 50 cm was developed from the burr hole site down to the anterior chest wall using a 
metallic trocar. Ventricular puncture is performed and the ventricular catheter is connected 
to a distal silastic catheter through an interposing Rickham CSF reservoir (Codman, Medos, 
Switzerland). The distal catheter is then passed down the subcutaneous tunnel and exits 
through the chest wall. The distal catheter is then connected to a closed external drainage 
system. No antibiotic is given post-operatively unless indicated for CSF or systemic 
infections. When CSF drainage is no longer required, removal of the catheter system is 
performed at the cranial end under general anesthesia. Alternatively, the distal catheter can 
be divided and plugged off over the chest wall under local anesthesia.  
4.1 Patient outcome 
We have reviewed 114 patients who have previously received the extended-tunnel EVD at 
our institution. There were 61 men and 53 women, ranging in age from 4 months to 90 years 
old (mean age = 52.6 years). The mean duration of CSF drainage was 20 days (median = 13 
days). Fourteen patients received more than one EVD which yielded a total of 133 
procedures. Thirty (22.6%) cases started with prior infections and 103 (77.4%) were 
infection-free at the time of insertion. Within the latter group, new infections developed in 
seven cases, yielding an overall infection rate of 6.8%. The mean time to infection was 9.7 
days (median = 5.0 days). A trend of increasing daily infection risk could be observed 
during the first five days. It remained relatively low and constant in the second week and 
then increased again after the 14th day. Only intraventricular injection of urokinase was 
identified as a weakly significant risk factor (relative risk = 4.78, 95% confidence interval = 
0.96 – 23.89, p = 0.039). Gender, age, primary neurosurgical diagnosis, immunodeficiency, 
diabetes mellitus, use of steroids, recent craniotomy, systemic sepsis at the time of and after 
‘long EVD’ insertion were not found to be statistically significant risk factors of infection.  
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Prior to the above study period, both conventional and the extended-tunnel EVDs may be 
used according to individual surgeons’ preferences. During this early phase, there was a 
total of 158 EVDs performed, including 33 (20.9%) long-EVDs. There were a total of 9 
infections, yielding an overall infection rate of 5.8%. The infection rates for long- and 
conventional EVDs were similar at 6.25% and 5.65%, respectively (p=0.896). Operation time, 
emergency versus elective operations, operating surgeons, age of patient, nature of disease, 
and duration of drainage were not found to be significant risk factors for infections. 
Diabetes mellitus and immunosuppression were found to be significantly associated with 
infections, with odd ratios of 5.39 (95% C.I.=1.33-21.86) and 6.71 (95% C.I.=1.14-39.46), 
respectively. Overall, our findings indicated that the extended-tunnel techqniue was 
associated with a similar risk of infection as the conventional EVD. Although some 
authorities may continue to advocate the extended-tunnel technique, there is no evidence to 
show that it adds any distinct advantage, and we have since stopped using the technique. 
5. Protocol-driven practice 
Some authorities have demonstrated that adhering to a predefined protocol of EVD 
insertion and maintenance that incorporates evidence-based measures as discussed above 
would significantly reduce the risk of EVD-related infections. Infection rates have been 
halved by strictly following a protocol involving aseptic insertion, use of prophylactic 
antibiotics, subcutaneous tunneling, no routine EVD revision, and minimal manipulation 
such as CSF sampling; violation of the protocol was associated with increased infection rate 
(Dasic, et al., 2006; Korinek, et al., 2005; Leverstein-van Hall, et al., 2010). Current evidence 
indicates that a strict EVD protocol should be adopted in neurosurgical centers. A protocol 
should cover the following aspects: 
Insertion of EVD 
- performed in the operating theatre whenever possible, with a minimal number of 
attending staff  
- performed in a dedicated clean treatment room if the procedure has to be done outside 
the operating theatre, with the surgeon and the assisting nurse dressed in sterile gown 
and gloves after proper hand hygiene measures 
- prophylactic antibiotics to cover skin flora before incision 
- shampoo the entire scalp with betadine, and disinfect with iodine alcohol 
- tunneling the catheter subcutaneously for at least five cm 
- covering the wound with sterile dressing 
Maintenance of EVD 
- respecting the close system as far as possible 
- avoid CSF sampling unless infection is clinically suspected 
- disinfect the connector and adopt strict aseptic technique if any breach of the system is 
needed 
- no routine EVD revision 
Removal of EVD 
- aseptic condition and disinfect site with povidone-iodine/alcohol 
- suture wound carefully to minimize CSF leakage 
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6. Conclusion  
EVD is a commonly performed neurosurgical procedure for the treatment of a variety of 
neurosurgical conditions including hydrocephalus. It is a useful and reliable temporizing 
method for ICP monitoring and the controlled release of CSF. Infection is a major and 
serious complication of EVD that may cause significant morbidities and even mortalities. 
Several risk factors of EVD-related infections have been identified and preventive measures 
aimed at reducing these factors have been developed. These include the use of prophylactic 
systemic antibiotics, antibiotics-coated catheters and subcutaneous catheter tunnelling. EVD 
that incorporate extended subcutaneous of over 30 cm have been used without the 
anticipated advantage of being able to reduce infection rates. The causation of EVD-related 
infections is likely to be multifactorial. Adopting a clearly defined protocol which addresses 
various aspects of insertion and maintenance is likely to be the effective approach to 
minimize the occurrence of EVD-related infections.  
7. References  
Abla, A. A., Zabramski, J. M., Jahnke, H. K., Fusco, D., & Nakaji, P. (2011). Comparison of 
two antibiotic-impregnated ventricular catheters: a prospective sequential series 
trial. Neurosurgery, 68(2), 437-442; discussion 442. 
Aucoin, P. J., Kotilainen, H. R., Gantz, N. M., Davidson, R., Kellogg, P., & Stone, B. (1986). 
Intracranial pressure monitors. Epidemiologic study of risk factors and infections. 
Am J Med, 80(3), 369-376. 
Bach, A., Eberhardt, H., Frick, A., Schmidt, H., Bottiger, B. W., & Martin, E. (1999). Efficacy 
of silver-coating central venous catheters in reducing bacterial colonization. Crit 
Care Med, 27(3), 515-521. 
Bader, M. K., Littlejohns, L., & Palmer, S. (1995). Ventriculostomy and intracranial pressure 
monitoring: in search of a 0% infection rate. Heart Lung, 24(2), 166-172. 
Beer, R., Pfausler, B., & Schmutzhard, E. (2009). Management of nosocomial external 
ventricular drain-related ventriculomeningitis. Neurocritical care, 10(3), 363-367. 
Blomstedt, G. C. (1985). Results of trimethoprim-sulfamethoxazole prophylaxis in 
ventriculostomy and shunting procedures. A double-blind randomized trial. J 
Neurosurg, 62(5), 694-697. 
Dasic, D., Hanna, S. J., Bojanic, S., & Kerr, R. S. (2006). External ventricular drain infection: 
the effect of a strict protocol on infection rates and a review of the literature. British 
journal of neurosurgery, 20(5), 296-300. 
Ehtisham, A., Taylor, S., Bayless, L., Klein, M. W., & Janzen, J. M. (2009). Placement of 
external ventricular drains and intracranial pressure monitors by neurointensivists. 
Neurocritical care, 10(2), 241-247. 
Fichtner, J., Guresir, E., Seifert, V., & Raabe, A. (2010). Efficacy of silver-bearing external 
ventricular drainage catheters: a retrospective analysis. Journal of neurosurgery, 
112(4), 840-846. 
Friedman, W. A., & Vries, J. K. (1980). Percutaneous tunnel ventriculostomy. Summary of 
100 procedures. J Neurosurg, 53(5), 662-665. 
www.intechopen.com
 
Hydrocephalus 
 
96
Gaberel, T., Magheru, C., Parienti, J. J., Huttner, H. B., Vivien, D., & Emery, E. (2011). 
Intraventricular Fibrinolysis Versus External Ventricular Drainage Alone in 
Intraventricular Hemorrhage: A Meta-Analysis. Stroke. 
Hetem, D. J., Woerdeman, P. A., Bonten, M. J., & Ekkelenkamp, M. B. (2010). Relationship 
between bacterial colonization of external cerebrospinal fluid drains and secondary 
meningitis: a retrospective analysis of an 8-year period. Journal of neurosurgery, 
113(6), 1309-1313. 
Hoefnagel, D., Dammers, R., Ter Laak-Poort, M. P., & Avezaat, C. J. (2008). Risk factors for 
infections related to external ventricular drainage. Acta neurochirurgica, 150(3), 209-
214; discussion 214. 
Holloway, K. L., Barnes, T., Choi, S., Bullock, R., Marshall, L. F., Eisenberg, H. M., et al. 
(1996). Ventriculostomy infections: the effect of monitoring duration and catheter 
exchange in 584 patients. J Neurosurg, 85(3), 419-424. 
Horan TC, G. R. (2004). Surveillance of nosocomial infections. Philadelphia. 
Kalfon, P., de Vaumas, C., Samba, D., Boulet, E., Lefrant, J. Y., Eyraud, D., et al. (2007). 
Comparison of silver-impregnated with standard multi-lumen central venous 
catheters in critically ill patients. Crit Care Med, 35(4), 1032-1039. 
Kaufmann, A. M., Lye, T., Redekop, G., Brevner, A., Hamilton, M., Kozey, M., et al. (2004). 
Infection rates in standard vs. hydrogel coated ventricular catheters. Can J Neurol 
Sci, 31(4), 506-510. 
Khanna, R. K., Rosenblum, M. L., Rock, J. P., & Malik, G. M. (1995). Prolonged external 
ventricular drainage with percutaneous long-tunnel ventriculostomies. J Neurosurg, 
83(5), 791-794. 
Korinek, A. M., Reina, M., Boch, A. L., Rivera, A. O., De Bels, D., & Puybasset, L. (2005). 
Prevention of external ventricular drain--related ventriculitis. Acta neurochirurgica, 
147(1), 39-45; discussion 45-36. 
Lackner, P., Beer, R., Broessner, G., Helbok, R., Galiano, K., Pleifer, C., et al. (2008). Efficacy 
of silver nanoparticles-impregnated external ventricular drain catheters in patients 
with acute occlusive hydrocephalus. Neurocritical care, 8(3), 360-365. 
Leung, G. K., Ng, K. B., Taw, B. B., & Fan, Y. W. (2007). Extended subcutaneous tunnelling 
technique for external ventricular drainage. British journal of neurosurgery, 21(4), 
359-364. 
Leverstein-van Hall, M. A., Hopmans, T. E., van der Sprenkel, J. W., Blok, H. E., van der 
Mark, W. A., Hanlo, P. W., et al. (2010). A bundle approach to reduce the incidence 
of external ventricular and lumbar drain-related infections. J Neurosurg, 112(2), 345-
353. 
Lo, C. H., Spelman, D., Bailey, M., Cooper, D. J., Rosenfeld, J. V., & Brecknell, J. E. (2007). 
External ventricular drain infections are independent of drain duration: an 
argument against elective revision. J Neurosurg, 106(3), 378-383. 
Lozier, A. P., Sciacca, R. R., Romagnoli, M. F., & Connolly, E. S., Jr. (2002). Ventriculostomy-
related infections: a critical review of the literature. Neurosurgery, 51(1), 170-181; 
discussion 181-172. 
www.intechopen.com
 
External Ventricular Drain Infections 
 
97 
Lozier, A. P., Sciacca, R. R., Romagnoli, M. F., & Connolly, E. S., Jr. (2008). Ventriculostomy-
related infections: a critical review of the literature. Neurosurgery, 62 Suppl 2, 688-
700. 
Lyke, K. E., Obasanjo, O. O., Williams, M. A., O'Brien, M., Chotani, R., & Perl, T. M. (2001). 
Ventriculitis complicating use of intraventricular catheters in adult neurosurgical 
patients. Clin Infect Dis, 33(12), 2028-2033. 
Mayhall, C. G., Archer, N. H., Lamb, V. A., Spadora, A. C., Baggett, J. W., Ward, J. D., et al. 
(1984). Ventriculostomy-related infections. A prospective epidemiologic study. N 
Engl J Med, 310(9), 553-559. 
McCarthy, P. J., Patil, S., Conrad, S. A., & Scott, L. K. (2010). International and specialty 
trends in the use of prophylactic antibiotics to prevent infectious complications 
after insertion of external ventricular drainage devices. Neurocritical care, 12(2), 220-
224. 
Park, P., Garton, H. J., Kocan, M. J., & Thompson, B. G. (2004). Risk of infection with 
prolonged ventricular catheterization. Neurosurgery, 55(3), 594-599; discussion 599-
601. 
Pfisterer, W., Muhlbauer, M., Czech, T., & Reinprecht, A. (2003). Early diagnosis of external 
ventricular drainage infection: results of a prospective study. J Neurol Neurosurg 
Psychiatry, 74(7), 929-932. 
Poon, W. S., Ng, S., & Wai, S. (1998). CSF antibiotic prophylaxis for neurosurgical patients 
with ventriculostomy: a randomised study. Acta Neurochir Suppl, 71, 146-148. 
Ragel, B. T., Browd, S. R., & Schmidt, R. H. (2006). Surgical shunt infection: significant 
reduction when using intraventricular and systemic antibiotic agents. J Neurosurg, 
105(2), 242-247. 
Roitberg, B. Z., Khan, N., Alp, M. S., Hersonskey, T., Charbel, F. T., & Ausman, J. I. (2001). 
Bedside external ventricular drain placement for the treatment of acute 
hydrocephalus. British journal of neurosurgery, 15(4), 324-327. 
Schade, R. P., Schinkel, J., Visser, L. G., Van Dijk, J. M., Voormolen, J. H., & Kuijper, E. J. 
(2005). Bacterial meningitis caused by the use of ventricular or lumbar 
cerebrospinal fluid catheters. J Neurosurg, 102(2), 229-234. 
Sonabend, A. M., Korenfeld, Y., Crisman, C., Badjatia, N., Mayer, S. A., & Connolly, E. S., Jr. 
(2011). Prevention of ventriculostomy-related infections with prophylactic 
antibiotics and antibiotic-coated external ventricular drains: a systematic review. 
Neurosurgery, 68(4), 996-1005. 
Stenager, E., Gerner-Smidt, P., & Kock-Jensen, C. (1986). Ventriculostomy-related infections-
-an epidemiological study. Acta neurochirurgica, 83(1-2), 20-23. 
Williams, T. A., Leslie, G. D., Dobb, G. J., Roberts, B., & van Heerden, P. V. (2011). Decrease 
in proven ventriculitis by reducing the frequency of cerebrospinal fluid sampling 
from extraventricular drains. J Neurosurg. 
Winfield, J. A., Rosenthal, P., Kanter, R. K., & Casella, G. (1993). Duration of intracranial 
pressure monitoring does not predict daily risk of infectious complications. 
Neurosurgery, 33(3), 424-430; discussion 430-421. 
www.intechopen.com
 
Hydrocephalus 
 
98
Wong, G. K., Poon, W. S., Wai, S., Yu, L. M., Lyon, D., & Lam, J. M. (2002). Failure of regular 
external ventricular drain exchange to reduce cerebrospinal fluid infection: result of 
a randomised controlled trial. J Neurol Neurosurg Psychiatry, 73(6), 759-761. 
Zabramski, J. M., Whiting, D., Darouiche, R. O., Horner, T. G., Olson, J., Robertson, C., et al. 
(2003). Efficacy of antimicrobial-impregnated external ventricular drain catheters: a 
prospective, randomized, controlled trial. J Neurosurg, 98(4), 725-730. 
www.intechopen.com
Hydrocephalus
Edited by Dr Sadip Pant
ISBN 978-953-51-0162-8
Hard cover, 214 pages
Publisher InTech
Published online 24, February, 2012
Published in print edition February, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Description of hydrocephalus can be found in ancient medical literature from Egypt as old as 500 AD.
Hydrocephalus is characterized by abnormal accumulation of cerebrospinal fluid (CSF) in the ventricles of the
brain. This results in the rise of intracranial pressure inside the skull causing progressive increase in the size of
the head, seizure, tunneling of vision, and mental disability. The clinical presentation of hydrocephalus varies
with age of onset and chronicity of the underlying disease process. Acute dilatation of the ventricular system
manifests with features of raised intracranial pressure while chronic dilatation has a more insidious onset
presenting as Adams triad. Treatment is generally surgical by creating various types of cerebral shunts. Role
of endoscopic has emerged lately in the management of hydrocephalus.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Anderson C.O. Tsang and Gilberto K.K. Leung (2012). External Ventricular Drain Infections, Hydrocephalus,
Dr Sadip Pant (Ed.), ISBN: 978-953-51-0162-8, InTech, Available from:
http://www.intechopen.com/books/hydrocephalus/external-ventricular-drain-infections
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
